Cooperation advances Alzheimer's disease prevention research

by GYMRThe future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the shar

Updated on: February 26,2024

Cooperation advances Alzheimer's disease prevention research

by GYMRThe future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the shar

Updated on:February 26,2024

Anxiety may be contagious, mouse study suggests

bySociety for NeuroscienceCredit: CC0 Public DomainSevere instances of stress experienced early in life (ELS) are a risk factor for developing neuropsychiatric diseases, such as anxiety, later i

Updated on: January 12,2024

Anxiety may be contagious, mouse study suggests

bySociety for NeuroscienceCredit: CC0 Public DomainSevere instances of stress experienced early in life (ELS) are a risk factor for developing neuropsychiatric diseases, such as anxiety, later i

Updated on:January 12,2024

Alzheimer's treatment holds promise for primary progressive aphasia patients

by Northwestern UniversityCredit: CC0 Public DomainNorthwestern Medicine scientists have discovered that an existing therapy frequently used to treat Alzheimer's disease might also work on pa

Updated on: April 08,2024

Alzheimer's treatment holds promise for primary progressive aphasia patients

by Northwestern UniversityCredit: CC0 Public DomainNorthwestern Medicine scientists have discovered that an existing therapy frequently used to treat Alzheimer's disease might also work on pa

Updated on:April 08,2024

Diagnosis of Alzheimer's becoming more common, but less severe

by Duke UniversityCredit: Duke UniversityAlzheimer's disease is the most common form of dementia, affecting nearly six million Americans. Aside from the incredible toll it takes on patients a

Updated on: April 18,2024

Diagnosis of Alzheimer's becoming more common, but less severe

by Duke UniversityCredit: Duke UniversityAlzheimer's disease is the most common form of dementia, affecting nearly six million Americans. Aside from the incredible toll it takes on patients a

Updated on:April 18,2024

Alzheimer's: Protective immune cells active decades before symptom onset

by German Center for Neurodegenerative DiseasesCredit: Pixabay/CC0 Public DomainIn individuals with a genetic predisposition to Alzheimer's disease, the immune cells of the brain—the "mi

Updated on: April 02,2024

Alzheimer's: Protective immune cells active decades before symptom onset

by German Center for Neurodegenerative DiseasesCredit: Pixabay/CC0 Public DomainIn individuals with a genetic predisposition to Alzheimer's disease, the immune cells of the brain—the "mi

Updated on:April 02,2024

Reducing early brain inflammation could slow Alzheimer's progression

by Experimental BiologyThis fluorescent photomicrograph shows astrocytes (green) and neurons (pink) in the dentate gyrus of rat hippocampus. Credit: Giorgia Menegoni, Sapienza, University of RomeIn a

Updated on: June 20,2024

Reducing early brain inflammation could slow Alzheimer's progression

by Experimental BiologyThis fluorescent photomicrograph shows astrocytes (green) and neurons (pink) in the dentate gyrus of rat hippocampus. Credit: Giorgia Menegoni, Sapienza, University of RomeIn a

Updated on:June 20,2024

First U.S. clinical trial using adult allogeneic stem cells to treat Alzheimer's disease

by Emory UniversityA new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) i

Updated on: March 07,2024

First U.S. clinical trial using adult allogeneic stem cells to treat Alzheimer's disease

by Emory UniversityA new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) i

Updated on:March 07,2024

How do we decide what to look at next? A computational model has the answer

byTechnical University of BerlinObject-based scanpath simulation in dynamic scenes. Credit: The image is derived from a frame of the field03 video of the VidCom dataset (Permission to Publish Co

Updated on: January 11,2024

How do we decide what to look at next? A computational model has the answer

byTechnical University of BerlinObject-based scanpath simulation in dynamic scenes. Credit: The image is derived from a frame of the field03 video of the VidCom dataset (Permission to Publish Co

Updated on:January 11,2024

Alzheimer's and an unusual molecular chaperone

by University of KonstanzPET scan of a human brain with Alzheimer's disease. Credit: public domainAmong the hallmarks of Alzheimer's disease are the Alzheimer fibrils, deposits of the tau

Updated on: April 20,2024

Alzheimer's and an unusual molecular chaperone

by University of KonstanzPET scan of a human brain with Alzheimer's disease. Credit: public domainAmong the hallmarks of Alzheimer's disease are the Alzheimer fibrils, deposits of the tau

Updated on:April 20,2024

New treatments for Alzheimer's and stroke revealed in several new studies

by American Physiological SocietyCredit: Pixabay/CC0 Public DomainThe results of three new studies indicate there could be new treatments for Alzheimer's and stroke. One study reveals a possi

Updated on: June 18,2024

New treatments for Alzheimer's and stroke revealed in several new studies

by American Physiological SocietyCredit: Pixabay/CC0 Public DomainThe results of three new studies indicate there could be new treatments for Alzheimer's and stroke. One study reveals a possi

Updated on:June 18,2024

Australia unprepared to move future Alzheimer's treatment into rapid clinical use

by RAND CorporationCredit: CC0 Public DomainAs in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from appro

Updated on: April 25,2024

Australia unprepared to move future Alzheimer's treatment into rapid clinical use

by RAND CorporationCredit: CC0 Public DomainAs in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from appro

Updated on:April 25,2024

IL-21 protein a key part of immune response to central nervous system infections

by Zachary Sweger,Pennsylvania State UniversityT cells infiltrating brains of MuPyV-infected mice captured in the Lukacher lab. Credit: Penn StateResearchers at Penn State College of Medicine no

Updated on: April 16,2024

IL-21 protein a key part of immune response to central nervous system infections

by Zachary Sweger,Pennsylvania State UniversityT cells infiltrating brains of MuPyV-infected mice captured in the Lukacher lab. Credit: Penn StateResearchers at Penn State College of Medicine no

Updated on:April 16,2024